BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 35192544)

  • 1. IL-9/STAT3/fatty acid oxidation-mediated lipid peroxidation contributes to Tc9 cell longevity and enhanced antitumor activity.
    Xiao L; Ma X; Ye L; Su P; Xiong W; Bi E; Wang Q; Xian M; Yang M; Qian J; Yi Q
    J Clin Invest; 2022 Apr; 132(7):. PubMed ID: 35192544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol negatively regulates IL-9-producing CD8
    Ma X; Bi E; Huang C; Lu Y; Xue G; Guo X; Wang A; Yang M; Qian J; Dong C; Yi Q
    J Exp Med; 2018 Jun; 215(6):1555-1569. PubMed ID: 29743292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-33 drives the antitumor effects of dendritic cells via the induction of Tc9 cells.
    Liu N; Jiang Y; Chen J; Nan H; Zhao Y; Chu X; Wang A; Wang D; Qin T; Gao S; Yi Q; Yue Y; Wang S
    Cell Mol Immunol; 2019 Jul; 16(7):644-651. PubMed ID: 30275536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-specific IL-9-producing CD8+ Tc9 cells are superior effector than type-I cytotoxic Tc1 cells for adoptive immunotherapy of cancers.
    Lu Y; Hong B; Li H; Zheng Y; Zhang M; Wang S; Qian J; Yi Q
    Proc Natl Acad Sci U S A; 2014 Feb; 111(6):2265-70. PubMed ID: 24469818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD36-mediated ferroptosis dampens intratumoral CD8
    Ma X; Xiao L; Liu L; Ye L; Su P; Bi E; Wang Q; Yang M; Qian J; Yi Q
    Cell Metab; 2021 May; 33(5):1001-1012.e5. PubMed ID: 33691090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tc9 cells, a new subset of CD8(+) T cells, support Th2-mediated airway inflammation.
    Visekruna A; Ritter J; Scholz T; Campos L; Guralnik A; Poncette L; Raifer H; Hagner S; Garn H; Staudt V; Bopp T; Reuter S; Taube C; Loser K; Huber M
    Eur J Immunol; 2013 Mar; 43(3):606-18. PubMed ID: 23254356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT3 Activation-Induced Fatty Acid Oxidation in CD8
    Zhang C; Yue C; Herrmann A; Song J; Egelston C; Wang T; Zhang Z; Li W; Lee H; Aftabizadeh M; Li YJ; Lee PP; Forman S; Somlo G; Chu P; Kruper L; Mortimer J; Hoon DSB; Huang W; Priceman S; Yu H
    Cell Metab; 2020 Jan; 31(1):148-161.e5. PubMed ID: 31761565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8
    Wang W; Green M; Choi JE; Gijón M; Kennedy PD; Johnson JK; Liao P; Lang X; Kryczek I; Sell A; Xia H; Zhou J; Li G; Li J; Li W; Wei S; Vatan L; Zhang H; Szeliga W; Gu W; Liu R; Lawrence TS; Lamb C; Tanno Y; Cieslik M; Stone E; Georgiou G; Chan TA; Chinnaiyan A; Zou W
    Nature; 2019 May; 569(7755):270-274. PubMed ID: 31043744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Converged Rab37/IL-6 trafficking and STAT3/PD-1 transcription axes elicit an immunosuppressive lung tumor microenvironment.
    Kuo IY; Yang YE; Yang PS; Tsai YJ; Tzeng HT; Cheng HC; Kuo WT; Su WC; Chang CP; Wang YC
    Theranostics; 2021; 11(14):7029-7044. PubMed ID: 34093869
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy.
    Adeshakin AO; Liu W; Adeshakin FO; Afolabi LO; Zhang M; Zhang G; Wang L; Li Z; Lin L; Cao Q; Yan D; Wan X
    Cell Immunol; 2021 Apr; 362():104286. PubMed ID: 33524739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF-a Is a Potent Stimulator of Tc9-Cell Differentiation.
    Yang S; Chen J; Zhang H; Jiang Y; Qin T; Gao S; Yue Y; Wang S
    J Immunother; 2020; 43(9):265-272. PubMed ID: 32842039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-10 receptor signaling promotes the maintenance of a PD-1
    Hanna BS; Llaó-Cid L; Iskar M; Roessner PM; Klett LC; Wong JKL; Paul Y; Ioannou N; Öztürk S; Mack N; Kalter V; Colomer D; Campo E; Bloehdorn J; Stilgenbauer S; Dietrich S; Schmidt M; Gabriel R; Rippe K; Feuerer M; Ramsay AG; Lichter P; Zapatka M; Seiffert M
    Immunity; 2021 Dec; 54(12):2825-2841.e10. PubMed ID: 34879221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th17 cells inhibit CD8
    Wang D; Yu W; Lian J; Wu Q; Liu S; Yang L; Li F; Huang L; Chen X; Zhang Z; Li A; Liu J; Sun Z; Wang J; Yuan W; Zhang Y
    J Hematol Oncol; 2020 Jun; 13(1):68. PubMed ID: 32503584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. STAT3 in CD8+ T Cells Inhibits Their Tumor Accumulation by Downregulating CXCR3/CXCL10 Axis.
    Yue C; Shen S; Deng J; Priceman SJ; Li W; Huang A; Yu H
    Cancer Immunol Res; 2015 Aug; 3(8):864-870. PubMed ID: 26025380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-27 enhances the survival of tumor antigen-specific CD8+ T cells and programs them into IL-10-producing, memory precursor-like effector cells.
    Liu Z; Liu JQ; Talebian F; Wu LC; Li S; Bai XF
    Eur J Immunol; 2013 Feb; 43(2):468-79. PubMed ID: 23225163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3/5-Dependent IL9 Overexpression Contributes to Neoplastic Cell Survival in Mycosis Fungoides.
    Vieyra-Garcia PA; Wei T; Naym DG; Fredholm S; Fink-Puches R; Cerroni L; Odum N; O'Malley JT; Gniadecki R; Wolf P
    Clin Cancer Res; 2016 Jul; 22(13):3328-39. PubMed ID: 26851186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased circulating IL-9-producing CD8
    Wang W; Cheng ZS; Chen YF; Lin YH
    Exp Ther Med; 2016 Dec; 12(6):4055-4060. PubMed ID: 28105134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty Acid Oxidation Controls CD8
    Lin R; Zhang H; Yuan Y; He Q; Zhou J; Li S; Sun Y; Li DY; Qiu HB; Wang W; Zhuang Z; Chen B; Huang Y; Liu C; Wang Y; Cai S; Ke Z; He W
    Cancer Immunol Res; 2020 Apr; 8(4):479-492. PubMed ID: 32075801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-6/STAT3 signaling as a promising target to improve the efficacy of cancer immunotherapy.
    Kitamura H; Ohno Y; Toyoshima Y; Ohtake J; Homma S; Kawamura H; Takahashi N; Taketomi A
    Cancer Sci; 2017 Oct; 108(10):1947-1952. PubMed ID: 28749573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of long-chain fatty acids in the tumor microenvironment drives dysfunction in intrapancreatic CD8+ T cells.
    Manzo T; Prentice BM; Anderson KG; Raman A; Schalck A; Codreanu GS; Nava Lauson CB; Tiberti S; Raimondi A; Jones MA; Reyzer M; Bates BM; Spraggins JM; Patterson NH; McLean JA; Rai K; Tacchetti C; Tucci S; Wargo JA; Rodighiero S; Clise-Dwyer K; Sherrod SD; Kim M; Navin NE; Caprioli RM; Greenberg PD; Draetta G; Nezi L
    J Exp Med; 2020 Aug; 217(8):. PubMed ID: 32491160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.